An American company is developing a treatment to combat loss of hearing.
Based on the concept of regenerative medicine, this drug – still in the clinical trial phase – aims to regenerate the cells responsible for hearing.
Already a subscriber? Log in.
Get 30% off with our ads free Premium Plan!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!